The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a s… [+2775 chars]Read More
FDA approves Mercks RSV shot for infants ramping up competition with Sanofi and AstraZeneca CNBC
